Spine biologics are used in spine surgery as lieu allografts and as support for bones in and around the spinal region. They can also be used as products that can cure the spine injuries or disorders or degenerated discs.
BiologicsSpine Surgery Market contains market size and forecasts of Biologics in Spine Surgery in global, including the following market information:
- Global Biologics in Spine Surgery Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global Biologics in Spine Surgery Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Biologics in Spine Surgery companies in 2021 (%)
The global Biologics in Spine Surgery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bone Graft Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biologics in Spine Surgery include Medtronic, J &J (DePuy Synthes), SeaSpine, Xtant Medical, Zimmer Biomet, Stryker, Straumann, Wright Medical Group and Hans Biomed and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biologics in Spine Surgery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologics in Spine Surgery Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Biologics in Spine Surgery Market Segment Percentages, by Type, 2021 (%)
- Bone Graft
- Bone Graft Substitute
- Platelet Rich Plasma (PRP)
- Other
Global Biologics in Spine Surgery Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Biologics in Spine Surgery Market Segment Percentages, by Application, 2021 (%)
Global Biologics in Spine Surgery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Biologics in Spine Surgery Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biologics in Spine Surgery revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Biologics in Spine Surgery revenues share in global market, 2021 (%)
- Key companies Biologics in Spine Surgery sales in global market, 2017-2022 (Estimated), (Units)
- Key companies Biologics in Spine Surgery sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Medtronic
- J &J (DePuy Synthes)
- SeaSpine
- Xtant Medical
- Zimmer Biomet
- Stryker
- Straumann
- Wright Medical Group
- Hans Biomed
- Arthrex
